cGKI Inhibitors
Santa Cruz Biotechnology now offers a broad range of cGKI Inhibitors. cGKI (cGMP-dependent protein kinase type I), also known as PRKG1, lowers the intracellular level of calcium and is important for the relaxation of vascular smooth muscle. cGKI Inhibitors offered by Santa Cruz inhibit cGKI and, in some cases, other intracellular cGMP and phosphorylation related proteins. View detailed cGKI Inhibitor specifications, including cGKI Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
SEE ALSO...
Items 21 to 24 of 24 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that prevents protein degradation, inducing apoptosis in multiple myeloma and mantle cell lymphoma cells. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Inhibits both EGFR and HER2, blocking cell growth signals in breast cancer cells, especially effective in HER2-positive breast cancer. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Inhibits Bruton's tyrosine kinase (BTK) in B cells, disrupting B-cell signaling and used in B-cell malignancies like CLL and mantle cell lymphoma. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $245.00 $1051.00 | 7 | |
Blocks androgen receptor (AR) signaling, suppressing the growth of prostate cancer cells by inhibiting the binding of androgens to AR. | ||||||